The inhibition rate with siFoxM1-Apt-CNBs was approximately three-fold that of siFoxM1-CNBs, together with the observation of an apparent inhibition of tumor proliferation (Figure 4(C)). The gene discussed is LYPLA2P1; the disease is neoplasm.